Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Decisions of Interest Image

Decisions of Interest

ALM Staff & Law Journal Newsletters

Recent decisions of importance to your practice.

Features

Quiz of the Month Image

Quiz of the Month

ALM Staff & Law Journal Newsletters

Test your knowledge of the law!

Features

John Gaal's Ethics Corner Image

John Gaal's Ethics Corner

ALM Staff & Law Journal Newsletters

Your ethics questions answered by the expert.

Features

Recent Developments from Around the States Image

Recent Developments from Around the States

ALM Staff & Law Journal Newsletters

National cases of interest to your practice.

News from the FDA Image

News from the FDA

ALM Staff & Law Journal Newsletters

All the latest information you need to know.

Features

Quiz of the Month Image

Quiz of the Month

ALM Staff & Law Journal Newsletters

Test your knowledge of the law!

Addressing the Conflict: FDA vs. Torts Image

Addressing the Conflict: FDA vs. Torts

Bert W. Rein, William A. McGrath, & Karyn K. Ablin

Our legal system supports two regulators of the safety of prescription drugs ' the U.S. Food and Drug Administration and courts applying the tort liability regime. The FDA's mission, while narrowly circumscribed in its early years, grew dramatically over the last half of the twentieth century. Today, the FDA administers the most comprehensive drug regulatory system in the world.

Eli Lilly Joins Others in Limiting Sales to Canada Image

Eli Lilly Joins Others in Limiting Sales to Canada

ALM Staff & Law Journal Newsletters

In October, Eli Lilly and Co. became the latest drug manufacturer to announce that it will begin limiting quantities of pharmaceutical products shipped to Canadian wholesalers.

Fen-Phen Again Image

Fen-Phen Again

ALM Staff & Law Journal Newsletters

Nearly 83,000 Fen-Phen users, including those whose claims have already been approved, may have their payments delayed or denied due to a new scheme instituted by the trustees of the Wyeth Settlement Trust, according to a lawsuit filed Nov. 5 by New York City-based law firm Napoli, Kaiser, Bern & Associates. The suit was filed on behalf of several individuals who are awaiting payment of damages from the trust, formerly known as The American Home Products Settlement Trust.

Features

News from the FDA Image

News from the FDA

ALM Staff & Law Journal Newsletters

All the latest FDA news and information you need to know.

Need Help?

  1. Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
  2. Need other assistance? email Customer Service or call 1-877-256-2472.

MOST POPULAR STORIES

  • Bankruptcy Sales: Finding a Diamond In the Rough
    There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
    Read More ›
  • Compliance Officers and Law Enforcement: Friends or Foes?
    <b><i>Part Two of a Two-Part Article</b></i><p>As we saw in Part One, regulators have recently shown a tendency to focus on compliance officers who they deem to have failed to ensure that the compliance and anti-money laundering (AML) programs that they oversee adequately prevented corporate wrongdoing, and there are several indications that regulators will continue to target compliance officers in 2018 in actions focused on Bank Secrecy Act/AML compliance.
    Read More ›
  • Artist Challenges Copyright Office Refusal to Register Award-Winning AI-Assisted Work
    Copyright law has long struggled to keep pace with advances in technology, and the debate around the copyrightability of AI-assisted works is no exception. At issue is the human authorship requirement: the principle that a work must have a human author to be eligible for copyright protection. While the Copyright Office has previously cited this "bedrock requirement of copyright" to reject registrations, recent decisions have focused on the role of human authorship in the context of AI.
    Read More ›